[1] Li XJ, Ren Y, Tian HM, et al. True insulin and proinsulin profile in normal glucose tolerant first Ren Y, Tian HM, et al.Elevated serum ferritin concentrations in a glucose-impaired population and in normal glucose tolera.DIABETES CARE, 2004,27(2)
[2] Chen X，Tian HM, et al.Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism wi.DIABETES RESEARCH AND CLINICAL PRACTICE, 2004,66(1)
[3] Hu YM, Tian HM, Liu R, et al.Gln-Arg192 polymorphism of paraoxonase 1 is associated with carotid intima-media thickness in patients of type 2 diabetes mellitus of Chinese..Diabetes Res Clin Pract, 2003,61(1)
[4] Chen X, Tian HM, Liu R, et al.Association between fasting and postprandial triglyceride levels and carotid intima-media thickness .CHINESE MED J, 2003,116(12)
[5] Tian HM, Han LC, Ren Yan et al. Lipoprotein(a) level and lipids in type 2 diabetic patients and their normoglycemic first-degree relatives in type 2 diabetic pedigrees.Diabetes Res Clin Pract, 2003,59(1)
[6] degree relatives in familial type 2 diabetic pedigrees. Diabetologia 2002,45(suppl 2):A32, 90.
[7] Shu J, Tian HM, Liu Rui, et al.Inhibitive effects of glucose and free fatty acids on proliferation of human vascular
gydjdsj.org.cn endothelial cells in vitro.Chinese Medical Journal, 2002,115(10)
[8] Hu YM, Tian HM, Liu R, et al.Difference in DNA sequences in SSU rDNA variable regions among pathogens isolated from different epidemic foci of visceral leishmaniasis in China.DIABETOLOGIA, 2002,45()
[9] Ren Y，Li XJ , Tian HM, el al. Molecular scanning of candidate mtDNA geng fragment in maternal diabetic pedigrees. Diabetes 2002,51(supplement2),A 616,2558.
[10] Ren Y，Tian HM ，Liu BW，et al .Abnormal changes of apolipoproteins in type2 diabetes mellitus associated with dyslipidemia and cornary heart disease ,The Endocrine Society (Program and abstracts)82nd Annual Meeting 2000,435,1795
[11] Ren Y，Tian HM，Liu R，et al. Apolipoprotein CIII gene SstI polymorphsim in patients of type 2 diabetes associated with hypertriglyceridemia in a Chinese population. The Endocrine Society (Program and abstracts 82nd Annual Meeting 2000;435,1805.
[12] 李建薇,田浩明,喻紅霖,張祥迅,趙
桂枝.那格列奈與
瑞格列奈治療2型糖尿病的隨機(jī)雙
盲對照研究.四川大學(xué)學(xué)報(bào)（醫(yī)學(xué)版), 2005,36(2)
[13] 趙月萍,田浩明.新診斷2型糖尿病短期胰島素強(qiáng)化治療.四川醫(yī)學(xué), 2005,26(2)
[14] 劉玉平,田浩明.庫欣綜合征與糖代謝紊亂.四川醫(yī)學(xué), 2005,26(2)
[15] 李亞,田浩明.2型糖尿病
膽囊結(jié)石與游離脂肪酸及胰島素抵抗的相關(guān)性分析.四川醫(yī)學(xué), 2005,26(2)
[16] 王曉輝,田浩明.2型糖尿病患者血漿皮質(zhì)醇
gydjdsj.org.cn、游離脂肪酸水平和胰島素抵抗.
中華內(nèi)分泌代謝雜志, 2004,20(3)
[17] 曹旭,田浩明.腹部肥胖導(dǎo)致胰島素抵抗和2型糖尿病的分子機(jī)制.華西醫(yī)學(xué), 2004,19(2)
[18] 陳德才,田浩明.
骨質(zhì)疏松癥的藥物治療循證.華西醫(yī)學(xué), 2004,19(1)
[19] 田浩明,魏東,賈
海燕.
葛根素治療糖尿病周圍神經(jīng)病變的系統(tǒng)評價(jià).中國循證醫(yī)學(xué)雜志, 2004,4(8)
[20] 田浩明,李啟富,王乃尊,吳桐,劉雅.國產(chǎn)那格列奈與瑞格列奈治療2型糖尿病的多中心隨機(jī)對照雙盲雙模擬臨床試驗(yàn).中國循證醫(yī)學(xué)雜志, 2004,4(7)
[21] 胡耀敏,田浩明,劉瑞,陳香.血漿致動脈硬化指數(shù)與2型糖尿病患者頸動脈內(nèi)膜中層厚度的相關(guān)性研究.四川大學(xué)學(xué)報(bào)（醫(yī)學(xué)版), 2004,35(5)
[22] 韓令川,田浩明,任艷,李秀鈞,王嘉南.中國人2型糖尿病家系中糖尿病患者及其一級親屬血脂和載脂蛋白的研究.中華內(nèi)分泌代謝雜志, 2004,19(6)
[23] 田浩明,李秀鈞.2型糖尿病的病因遺傳學(xué)研究進(jìn)展.國外醫(yī)學(xué)·內(nèi)分泌學(xué)分冊, 2002,22(2)
[24] 田浩明.循證醫(yī)學(xué)在糖尿病研究和治療中的應(yīng)用.四川醫(yī)學(xué), 2002,23(9)
[25] 田浩明,王玉華,任艷.治療中的2型糖尿病患者空腹及三餐后4小時(shí)
甘油三酯水平的觀察.華西醫(yī)科大學(xué)學(xué)報(bào), 2002,33(4)
[26] 田浩明,李明初,梁藎忠.
Reiter綜合征1例報(bào)告.中國全科醫(yī)學(xué), 2001,4(9)
[27] 田浩明,李明初,梁藎忠.
谷氨酸脫羧酶抗體測定對不易分型成人糖尿病的臨床意義.華西醫(yī)科大學(xué)學(xué)報(bào), 2001,32(1)
[28] 田浩明,蘇進(jìn).游離脂肪酸與肥胖和糖尿病.遼寧實(shí)用糖尿病雜志, 2000,2(2)
聯(lián)系方式:
電話： 028-8542257 郵箱:hmtian999@yahoo.com.cn
上一頁 [1] [2] [3] 下一頁
